And donating blood three times per year could possibly save you, according to researchers at the Francis Crick Institute in ...

Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...

Driven, athletic, and a role model to his community, 20-year-old Eddie Kaufman has been fighting an aggressive form of blood ...

High body mass index affects outcomes in acute lymphoblastic leukemia (ALL), highlighting the need for targeted interventions ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

DelveInsight’s, “Chronic Lymphocytic Leukemia Pipeline Insight 2025” report provides comprehensive insights about 55+ companies and 60+ pipeline drugs in Chronic Lymphocytic Leukemia (CLL) pipeline ...

The 54-year-old CEO of Sermo is running relentlessly in an effort to raise $1 million for stem cell transplant research.

During the early days of research on bone marrow transplants, the procedure was difficult for patients to endure and had a ...

Debiopharm ( a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to ...

VANFLYTA (quizartinib) has been approved by Health Canada for use in combination with standard cytarabine and anthracycline ...

A local car dealership has sent warm wishes to Franciscan cancer patients.